Items Tagged ‘Edith Perez’

July 26, 2012

Mayo Clinic in the News Weekly Highlights


July 26, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Kelley Luckstein Public Affairs Associate Guest Editor […]

View full entry

Tags: Alzheimer's Treatment, Associated Press, Dartmouth-Hitchcock Medical Center, Dr. David Hayes, Dr. Michael Joyner, Dr. Ron Petersen, Edith Perez, heat-related medical problems, Mayo Clinic Comprehensive Cancer Center, Pfizer, Post Bulletin, Reader's Digest Canada

February 20, 2012

Flashy props draw attention to marathon’s cause


… “Our hair is always pink to celebrate for the cause,” Bob Liner said Sunday at the fifth annual event that begins and ends at Mayo Clinic Jacksonville. Founded by First Coast News anchor Donna Deegan and Mayo oncologist and cancer researcher Edith Perez, the race raises money for breast cancer research and to financially […]

View full entry

Tags: Bob Liner, Donna Deegan, Edith Perez, First Coast News, pink hair

February 13, 2012

Donna Deegan, Edith Perez heartened by progress, but they’re not finished


Edith Perez and her Mayo Clinic research team think they’re on the verge of a significant breakthrough in their mission to finish breast cancer. Donna Deegan wants to make sure they get there. Deegan and Perez joined forces five years ago to create the 26.2 with Donna The National Marathon to Finish Breast Cancer, which […]

View full entry

Tags: 26.2 with Donna, Donna Deegan, Edith Perez, Mayo Clinic's Breast Cancer Translational Genomics Program, The National Marathon to Finish Breast Cancer

January 16, 2012

HER2 proteins do not predict breast cancer patient’s outcome after Herceptin treatment


Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient’s outcome after treatment for HER2-Positive Breast Cancer with Herceptin, say Mayo Clinic researchers. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that […]

View full entry

Tags: Edith Perez, Herceptin, M.D.

December 8, 2011

Drugs Keep Tumors at Bay


Two drugs significantly extend the time that women with metastatic breast cancer can live without their tumors growing, potentially changing the landscape for 80% of patients with the disease, according to two separate studies released Wednesday…”The magnitude of the impact seen in these trials is sufficient to incorporate the medicines in day-to-day practice,” said Edith […]

View full entry

Tags: Breast Cancer, Edith Perez

December 2, 2011

Study Adds Support to Mammograms Starting at Age 40


In the latest findings to fuel the debate on when to start getting mammograms, new research adds support to those suggesting that annual breast X-rays should begin at age 40… The new findings are unlikely to put an end to the debate, says Edith Perez, MD, a breast cancer specialist at the Mayo Clinic in […]

View full entry

Tags: Edith Perez, mammograms, MD

July 15, 2009

A conversation with Dr. Edith Perez

By Kelley Luckstein

Dr. Edith Perez is a professor of medicine at the Mayo Clinic in Jacksonville, FL, and the co-principal investigator and North American coordinator for the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) clinical trial, an international phase III clinical trial that aims to define the optimal treatment for early stage HER2-positive breast cancer. The National […]

View full entry

Tags: Add new tag, ALTTO, Breast Cancer, Cancer, Edith Perez, Jacksonville, MCJ

Contact Us · Privacy Policy